Ana Maria Gonzalez

Ana Maria Gonzalez is a seasoned professional in the field of precision medicine, currently serving as the Director of Precision Medicine at Regeneron since August 2018, after holding the position of Associate Director. Prior experience includes roles as Associate Director of Translational Medicine and Senior Scientist/Biology Project Lead at Agenus, focusing on the mechanisms of action of checkpoint-specific antibodies. Ana Maria's academic background includes a Postdoctorate Fellowship at Harvard Medical School specializing in HIV immunity and pathogenesis, a PhD in Immunology and Virology from The Ohio State University, and an MD from Pontificia Universidad Javeriana. Early research experience includes a role as a Research Assistant at Genetics Institute and internships in clinical settings, including Sogamoso Regional Hospital and Miami Children's Hospital.